Treatment Modification to Reduce Symptom Burden in Hemodialysis

Completed · Not applicable

Conditions studied: End Stage Renal Disease

In brief

Many patients on hemodialysis experience high rates of symptom burden, such as pain, depression, anxiety and difficulty breathing. This study seeks to reduce these symptoms by modifying the usual guidelines used to manage patients on hemodialysis. For example, rather than trying to keep serum phosphorus below 5.5, patients enrolled in this study may have treatment goals of less than 6.5, in order to reduce the number of pills they need to take and potentially reduce harmful side effects. Blood pressure and serum parathyroid hormone goals will also be modified, to see if these modifications help hemodialysis patients feel better.

Key facts

Study ID

NCT01775800

Run by

The Rogosin Institute

People needed

16

Starts

2013-01-01

Expected to finish

2014-09-01

Last updated by the study team

2018-10-09

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• hemodialysis patient
• transplant ineligible

You may not qualify if…

• dementia
• unable to answer questionnaires for any reason

Where it is running

• The Rogosin Institute — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.